Anagenics (ASX:AN1) Other Long-Term Liabilities: A$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Anagenics Other Long-Term Liabilities?

Anagenics ASX:AN1 Other Long-Term Liabilities is A$0.00 Mil as of Jun. 2026. The stock has 7 warning signs investors should review.

Anagenics's other long-term liabilities for the quarter that ended in Jun. 2026 was A$0.00 Mil.

Anagenics's quarterly other long-term liabilities increased from Jun. 2025 (A$-0.00 Mil) to Dec. 2025 (A$0.00 Mil) but then stayed the same from Dec. 2025 (A$0.00 Mil) to Jun. 2026 (A$0.00 Mil).

Anagenics's annual other long-term liabilities declined from Jun. 2024 (A$0.01 Mil) to Jun. 2025 (A$-0.00 Mil) but then increased from Jun. 2025 (A$-0.00 Mil) to Jun. 2026 (A$0.00 Mil).

Anagenics Other Long-Term Liabilities Related Terms

Anagenics Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Anagenics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anagenics Other Long-Term Liabilities Chart

Anagenics Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.00 0.01 -0.00 0.00

Anagenics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 -0.00 0.00 0.00

Anagenics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of A$0.00 Mil mean?
Anagenics (ASX:AN1) has a Other Long-Term Liabilities of A$0.00 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Anagenics and its competitors.
Is Anagenics' Other Long-Term Liabilities too high?
Anagenics' current Other Long-Term Liabilities is A$0.00 Mil.
How does Anagenics' Other Long-Term Liabilities compare to PG and CL?
Anagenics' Other Long-Term Liabilities of A$0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Consumer Packaged Goods company?
A good Other Long-Term Liabilities depends on the Consumer Packaged Goods industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Anagenics and its competitors. Anagenics's current Other Long-Term Liabilities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anagenics stock overvalued right now?
Anagenics (ASX:AN1) has a current Other Long-Term Liabilities of A$0.00 Mil. The current Other Long-Term Liabilities is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Anagenics (ASX:AN1), the current Other Long-Term Liabilities is A$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anagenics Business Description

Address 55 Clarence Street, Suite 204, Level 2, Sydney, NSW, AUS, 2000
Anagenics Ltd is a health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.